69 related articles for article (PubMed ID: 24088132)
1. CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer.
Stenstedt K; Travica S; Guo J; Barragan I; Pors K; Patterson L; Edler D; Mkrtchian S; Johansson I; Ingelman-Sundberg M
Pharmacogenomics; 2013 Oct; 14(13):1615-22. PubMed ID: 24088132
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins.
Travica S; Pors K; Loadman PM; Shnyder SD; Johansson I; Alandas MN; Sheldrake HM; Mkrtchian S; Patterson LH; Ingelman-Sundberg M
Clin Cancer Res; 2013 Jun; 19(11):2952-61. PubMed ID: 23589180
[TBL] [Abstract][Full Text] [Related]
3. CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk.
Gervasini G; de Murillo SG; Ladero JM; Agúndez JA
Pharmacogenomics; 2010 Jul; 11(7):919-25. PubMed ID: 20602611
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A; Nekvindova J; Travica S; Lee MY; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
Mol Pharmacol; 2010 Dec; 78(6):1004-11. PubMed ID: 20805301
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.
Bart AG; Morais G; Vangala VR; Loadman PM; Pors K; Scott EE
Drug Metab Dispos; 2022 Jan; 50(1):49-57. PubMed ID: 34607808
[TBL] [Abstract][Full Text] [Related]
6. Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors.
Choong E; Guo J; Persson A; Virding S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
PLoS One; 2015; 10(4):e0122820. PubMed ID: 25844926
[TBL] [Abstract][Full Text] [Related]
7. The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases.
Stenstedt K; Hallstrom M; Lédel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
Acta Oncol; 2014 Jul; 53(7):885-91. PubMed ID: 24625228
[TBL] [Abstract][Full Text] [Related]
8. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
[TBL] [Abstract][Full Text] [Related]
9. CYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancer.
Cárdenas-Rodríguez N; Lara-Padilla E; Bandala C; López-Cruz J; Uscanga-Carmona C; Lucio-Monter PF; Floriano-Sánchez E
Asian Pac J Cancer Prev; 2012; 13(3):837-46. PubMed ID: 22631658
[TBL] [Abstract][Full Text] [Related]
10. The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot study.
Edler D; Stenstedt K; Ohrling K; Hallström M; Karlgren M; Ingelman-Sundberg M; Ragnhammar P
Eur J Cancer; 2009 Mar; 45(4):705-12. PubMed ID: 19118998
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.
Chung FF; Mai CW; Ng PY; Leong CO
Curr Cancer Drug Targets; 2016; 16(1):71-8. PubMed ID: 26563883
[TBL] [Abstract][Full Text] [Related]
12. The expression of CYP2W1: a prognostic marker in colon cancer.
Stenstedt K; Hallstrom M; Johansson I; Ingelman-Sundberg M; Ragnhammar P; Edler D
Anticancer Res; 2012 Sep; 32(9):3869-74. PubMed ID: 22993331
[TBL] [Abstract][Full Text] [Related]
13. Expression of CYP2W1 in colon tumors: regulation by gene methylation.
Gomez A; Karlgren M; Edler D; Bernal ML; Mkrtchian S; Ingelman-Sundberg M
Pharmacogenomics; 2007 Oct; 8(10):1315-25. PubMed ID: 17979506
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.
Karlgren M; Gomez A; Stark K; Svärd J; Rodriguez-Antona C; Oliw E; Bernal ML; Ramón y Cajal S; Johansson I; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2006 Mar; 341(2):451-8. PubMed ID: 16426568
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms and haplotype structures of the human CYP2W1 gene in a Japanese population.
Hanzawa Y; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Drug Metab Dispos; 2008 Feb; 36(2):349-52. PubMed ID: 17998294
[TBL] [Abstract][Full Text] [Related]
16. The CYP2W1 enzyme: regulation, properties and activation of prodrugs.
Guo J; Johansson I; Mkrtchian S; Ingelman-Sundberg M
Drug Metab Rev; 2016 Aug; 48(3):369-78. PubMed ID: 27257736
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 2W1 (CYP2W1) - ready for use as the biomarker and drug target for cancer?
Pan Y; Ong EC
Xenobiotica; 2017 Oct; 47(10):923-932. PubMed ID: 27690753
[TBL] [Abstract][Full Text] [Related]
18. Identification of Genetic Polymorphisms of CYP2W1 in the Three Main Chinese Ethnicities: Han, Tibetan, and Uighur.
Li Y; Kang X; Yang G; Dai P; Chen C; Wang H
Drug Metab Dispos; 2016 Sep; 44(9):1510-5. PubMed ID: 27307299
[TBL] [Abstract][Full Text] [Related]
19. Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas.
Nolé P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
PLoS One; 2016; 11(9):e0162379. PubMed ID: 27598485
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of human cytochrome P450 2W1 and its interactions with substrates.
Li W; Tang Y; Hoshino T; Neya S
J Mol Graph Model; 2009 Sep; 28(2):170-6. PubMed ID: 19596602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
